| scholarly article | Q13442814 |
| P2093 | author name string | Li Wang | |
| Pei Xu | |||
| Pingping Shen | |||
| Weiwei Wu | |||
| Yangli Jin | |||
| P2860 | cites work | Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature | Q26823788 |
| Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. | Q27851589 | ||
| Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature | Q28072196 | ||
| Clinicopathological Study of 18 Cases of Inflammatory Myofibroblastic Tumors with Reference to ALK-1 Expression: 5-Year Experience in a Tertiary Care Center | Q33729669 | ||
| Epithelioid inflammatory myofibroblastic sarcoma with recurrence after extensive resection: significant clinicopathologic characteristics of a rare aggressive soft tissue neoplasm | Q35854414 | ||
| PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: updated survival data | Q36363579 | ||
| Incomplete Intestinal Obstruction Caused by a Rare Epithelioid Inflammatory Myofibroblastic Sarcoma of the Colon: A Case Report | Q36421076 | ||
| Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature | Q37129515 | ||
| Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review. | Q37362414 | ||
| Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors | Q38016070 | ||
| The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck | Q38211236 | ||
| ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma | Q39016560 | ||
| Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma | Q42181725 | ||
| Clever crows or unbalanced birds? | Q43140961 | ||
| Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. | Q43472106 | ||
| Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case | Q47673400 | ||
| A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib. | Q54198800 | ||
| Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma. | Q54977985 | ||
| PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer | Q57073426 | ||
| Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor | Q73182222 | ||
| Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study | Q77089681 | ||
| Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors | Q77926025 | ||
| WHO Classification of Soft Tissue and Bone, fourth edition: summary and commentary | Q87249074 | ||
| Epithelioid Inflammatory Myofibroblastic Sarcoma | Q88289401 | ||
| [Epithelioid inflammatory myofibroblastic sarcoma of small bowel mesentery: report of a case] | Q89514801 | ||
| P433 | issue | 5 | |
| P921 | main subject | epithelioid inflammatory myofibroblastic sarcoma | Q60195370 |
| P304 | page(s) | 1738-1744 | |
| P577 | publication date | 2019-05-01 | |
| P1433 | published in | International Journal of Clinical and Experimental Pathology | Q6051341 |
| P1476 | title | Epithelioid inflammatory myofibroblastic sarcoma of stomach: diagnostic pitfalls and clinical characteristics | |
| P478 | volume | 12 |
Search more.